APPLICATION
NDA017015
TYPE
NDA
ORIGINAL APPROVAL
1972-10-24
LATEST ACTION
2010-11-24
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
PAVULON · ReferenceDiscontinued
PANCURONIUM BROMIDE 2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
PAVULON · ReferenceDiscontinued
PANCURONIUM BROMIDE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
Approval history
2000-03-22Manufacturing (CMC) · Supplement 22 · priorityAP
1995-05-17Manufacturing (CMC) · Supplement 20 · priorityAP
1994-02-28Manufacturing (CMC) · Supplement 21 · priorityAP
1993-03-29Manufacturing (CMC) · Supplement 16 · priorityAP
1991-07-25Labeling · Supplement 18 · priorityAP
1990-10-05Manufacturing (CMC) · Supplement 19 · priorityAP
1987-10-08Manufacturing (CMC) · Supplement 13 · priorityAP
1986-06-27Manufacturing (CMC) · Supplement 11 · priorityAP
1986-04-02Labeling · Supplement 10 · priorityAP
1982-03-17Labeling · Supplement 9 · priorityAP
1982-03-17Manufacturing (CMC) · Supplement 8 · priorityAP
1977-01-26Manufacturing (CMC) · Supplement 7 · priorityAP
1975-09-22Labeling · Supplement 6 · priorityAP
1974-11-11Labeling · Supplement 3 · priorityAP
1974-10-08Manufacturing (CMC) · Supplement 5 · priorityAP
1972-10-24Type 1 - New Molecular Entity · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.